Serum Cholesterol in Wisconsin Epidemiologic Study of Diabetic Retinopathy
- Barbara E K Klein, MD, MPH,
- Scot E Moss, MA,
- Ronald Klein, MD, MPH and
- Tanya S Surawicz, MPH
- Address Correspondence and Reprint Requests to Barbara E.K Klein, MD, MPH, University of Wisconsin, Department of Ophthalmology, 600 Highland Avenue, Madison, WI 53792.
Abstract
Objective To describe serum total and high-density lipoprotein (HDL) cholesterol in a sample of people with diabetes.
Research Design and Methods Subjects were those who participated in the 1984-1986 Wisconsin Epidemiologic Study of Diabetic Retinopathy. Data were from three groups of subjects: 304 younger-onset and 185 older-onset people taking insulin and 162 older-onset individuals not taking insulin. Serum lipids, duration of diabetes, glycosylated hemoglobin, diastolic blood pressure, sex, age, serum creatinine, units of insulin per kiliogram per day, smoking status, serum C-peptide level, and alcohol use were analyzed statistically.
Results In subjects taking insulin, glycosylated hemoglobin was correlated most strongly with total cholesterol. In those not taking insulin, C-peptide was correlated most strongly. In subjects taking insulin, the units used per day (fewer)and sex (female) were significantly associated with higher HDL cholesterol, and in both older-onset groups, serum C-peptide was significantly associated with lower HDL cholesterol. Mean total cholesterol levels were generally higher and mean HDL cholesterol levels were generally lower than those found in a nondiabetic comparison group.
Conclusions By the National Cholesterol Education Program guidelines, 17% of younger-onset and 30% of older-onset insulin users and 32% of olderonset subjects not taking insulin were in the high-risk range for total cholesterol. Lower levels of glycosylated hemoglobin might result in lower cholesterol levels.
- Received December 3, 1990.
- Accepted October 2, 1991.
- Copyright © 1992 by the American Diabetes Association











